跳至主要内容
临床试验/NCT05389683
NCT05389683已完成不适用

Assessment of Improvement in Food Sensitivity Related Symptoms on Employment of Personalized Elimination Diet

Vibrant America Clinical Lab18 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年1月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
18
主要终点
Improvement in severity of food sensitivity symptoms

研究概览

简要总结

The goal is to identify food sensitivity in patients and assess whether the avoidance of the reaction-inducing foods via an 'elimination diet' leads to improvement in patient symptoms and overall well-being.

详细描述

After seeking appropriate consent, patients' blood samples will be tested for the reactivity toward 262 foods using peptide and protein microarrays. Food protein extraction will be carried out in different solvents such as water and alcohol. The peptide microarrays will synthesize the entire food proteins as peptides in situ while the protein microarrays will test for water-soluble and alcohol-soluble fractions. Thus, food sensitivity testing will be carried out at 3 different levels including water-soluble proteins, alcohol-soluble proteins, and peptides. Patients' blood samples can be tested at all 3 levels or a combination of these. This decision lies at the discretion of the physician.

Based on the test results and as per the physician's recommendations, a suitable elimination diet will be suggested to the patient. Personalized diet suggestions for each patient will be made by the physician. The patient will follow the diet for 4 weeks and blood samples will be tested again on completion of the diet, using peptides and protein microarrays. Additionally, based on the physician's recommendations, the time duration for which a patient follows the personalized elimination diet can be modified.

The patients will periodically have to fill out diagnostic questionnaires which will help assess the changes in their food sensitivity-related symptoms. Changes in the blood biomarkers and improvement in symptoms will be monitored during the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged between 18 to 65 years.
  • Patients suffering from food sensitivity symptoms
  • Patients having Immunoglobulin G (IgG) and Immunoglobulin A (IgA)-mediated food reactions leading to food sensitivity
  • Patients agreeing to follow the diet per testing
  • Patients willing to provide an informed consent

排除标准

  • Patients suffering from chronic medical conditions like cancer
  • Pregnant subjects
  • Patients who have recently used antibiotics
  • Patients who have previously undergone treatments for food allergies/sensitivities
  • Patients who have been assigned an elimination diet before
  • Patients who are already following a restricted diet of any kind
  • Patients unwilling/unable to provide informed consent

结局指标

主要结局

Improvement in severity of food sensitivity symptoms

时间窗: Baseline; Week 1; Week 2; Week 3; Week 4

Food Sensitivity - Symptom Severity Scale (FS - SSS) is a 16-item questionnaire that will assess the severity of the patient's food sensitivity-related symptoms. The scores range from 0 (none) to 5 (severe).

Improvement in blood biomarker profile

时间窗: Baseline - 4 weeks

The peptide and protein microarrays will be used to test patients' blood samples prior to and post-employment of the elimination diet, and changes in the blood biomarker profile will be monitored. Testing will be carried out at baseline and then after 4 weeks, on completion of the diet.

次要结局

  • Food sensitivity - Global Improvement Scale (FS-GIS)(Week 4)
  • Food Sensitivity - Quality of Life Questionnaire (FS-QoL)(Baseline; Week 4)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Hari Krishnamurthy

Director - Biomedical Engineering

Vibrant America Clinical Lab

研究点 (18)

Loading locations...

相似试验

Effect of Personalized Elimination Diet on Food... | 临床试验